Venus Medtech
Venus Medtech is a leading Chinese medical device company focused on transcatheter solutions for structural heart disease.
The company has built a comprehensive product pipeline covering aortic, pulmonary, mitral, and tricuspid valve disease, along with supporting surgical and interventional products. Its portfolio includes TAVR, TPVR, TMVR, and TTVR technologies, with products used across more than 60 countries and regions.
Venus Medtech is listed on the Hong Kong Stock Exchange under stock code 02500. With global R&D capabilities and international market reach, the company aims to become a global leader in structural heart disease treatment by delivering innovative, clinically focused cardiovascular solutions.
Manufacturer’s website: https://www.venusmedtech.com/
